Phase 1 Trial of ASTX727 in Subjects With Lower-risk Myelodysplastic Syndromes

NCT03906695 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Lower-risk Myelodysplastic

Interventions

DRUG: ASTX727
DRUG: ASTX727
DRUG: ASTX727
DRUG: ASTX727
DRUG: ASTX727

Sponsor

Otsuka Pharmaceutical Co., Ltd.